Registry to evaluate catheter-assisted procedures for structural heart disease
Interventional Structural Registry - LuEbeck
This study looks at how catheter-assisted procedures affect people with structural heart disease to see how safe and effective they are over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Luebeck Academic / other |
| Locations | 1 site (Lübeck, Schleswig-Holstein) |
| Trial ID | NCT06977139 on ClinicalTrials.gov |
What this trial studies
This registry aims to investigate the impact of catheter-assisted procedures on patients with structural heart disease, focusing on clinical morbidity and mortality. It will document various parameters, including underlying diseases, safety, and effectiveness of the procedures over time. The study will also evaluate the long-term prognosis of patients following these interventions, providing valuable insights into their outcomes and the effectiveness of concomitant therapies.
Who should consider this trial
Good fit: Ideal candidates for this registry are individuals diagnosed with structural heart disease who can provide informed consent.
Not a fit: Patients under 18 years of age or those unable to provide consent will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of treatment outcomes for patients with structural heart disease, leading to improved care strategies.
How similar studies have performed: Other observational studies have shown success in evaluating catheter-assisted procedures, indicating that this approach is supported by prior research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Structural heart disease Exclusion Criteria: * Patients without consent/information * Age ≤ 18 years
Where this trial is running
Lübeck, Schleswig-Holstein
- Universitätsklinikum Schleswig-Holstein — Lübeck, Schleswig-Holstein, Germany (Recruiting)
Study contacts
- Study coordinator: Ingo Eitel, Prof. Dr.
- Email: cvro@uksh.de
- Phone: +49 451 500 44501
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.